(Updated - December 13, 2022 6:32 AM EST)

Goldman Sachs analyst Chris Shibutani upgraded Pfizer (NYSE: PFE) from Neutral ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE